{"transactions":[{"id":4623140,"issuer":{"id":6324,"kind":"organization","name":"NovaBridge Biosciences","symbol":"NBP"},"owners":[{"id":36207,"kind":"person","name":"Dennis Phillip Andrew","position":1,"cik":"0002089237","reported_name":"Dennis Phillip Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Share Units","published_at":"2026-09-21T20:05:06.000Z","date":"2026-09-17","kind":"exercise","planned":false,"acquired":false,"shares":10302,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ADS."},{"field":"shares","element":"transactionShares","label":"F8","text":"Reported securities represent ADSs."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"On June 17, 2024, the Reporting Person was granted 164,840 RSUs. The RSUs vested or shall vest over four years, with one-fourth vesting on the first anniversary of the grant date and the balance vesting ratably over the subsequent 12 quarters on the 17th day of each third month."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F9","text":"On June 17, 2024, the Reporting Person was granted 164,840 RSUs. The RSUs vested or shall vest over four years, with one-fourth vesting on the first anniversary of the grant date and the balance vesting ratably over the subsequent 12 quarters on the 17th day of each third month."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares (\"ADS\"). Each 10 ADSs represent 23 Ordinary Shares of the Issuer."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F8","text":"Reported securities represent ADSs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F8","text":"Reported securities represent ADSs."}],"balance_after":72120,"derivative":{"underlying":"Ordinary Shares","underlying_shares":10302},"source":{"system":"sec-edgar","filing":"0002089237-26-000008","document":"form4-09212026_040901.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2089237/000208923726000008/form4-09212026_040901.xml","form_type":"4"}},{"id":4623139,"issuer":{"id":6324,"kind":"organization","name":"NovaBridge Biosciences","symbol":"NBP"},"owners":[{"id":36207,"kind":"person","name":"Dennis Phillip Andrew","position":1,"cik":"0002089237","reported_name":"Dennis Phillip Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2026-09-21T20:05:06.000Z","date":"2026-09-18","kind":"sale","planned":false,"acquired":false,"shares":8209,"price":0.71,"value":5828.39,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares (\"ADS\"). Each 10 ADSs represent 23 Ordinary Shares of the Issuer."},{"field":"shares","element":"transactionShares","label":"F5","text":"Reported securities are represented by 3,569 ADSs."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Reported sales price represents the converted sales price of the ADSs of $1.6247."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F7","text":"Reported securities are represented by 75,403 ADSs."}],"balance_after":173427,"source":{"system":"sec-edgar","filing":"0002089237-26-000008","document":"form4-09212026_040901.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2089237/000208923726000008/form4-09212026_040901.xml","form_type":"4"}},{"id":4623138,"issuer":{"id":6324,"kind":"organization","name":"NovaBridge Biosciences","symbol":"NBP"},"owners":[{"id":36207,"kind":"person","name":"Dennis Phillip Andrew","position":1,"cik":"0002089237","reported_name":"Dennis Phillip Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2026-09-21T20:05:06.000Z","date":"2026-09-17","kind":"exercise","planned":false,"acquired":true,"shares":23695,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares (\"ADS\"). Each 10 ADSs represent 23 Ordinary Shares of the Issuer."},{"field":"shares","element":"transactionShares","label":"F2","text":"Reported securities are represented by 10,302 ADSs."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ADS."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Reported securities are represented by 78,972 ADSs."}],"balance_after":181636,"source":{"system":"sec-edgar","filing":"0002089237-26-000008","document":"form4-09212026_040901.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2089237/000208923726000008/form4-09212026_040901.xml","form_type":"4"}},{"id":4615928,"issuer":{"id":6324,"kind":"organization","name":"NovaBridge Biosciences","symbol":"NBP"},"owners":[{"id":35580,"kind":"person","name":"Cao Sean Wuxiong","position":1,"cik":"0002109966","reported_name":"Cao Sean Wuxiong","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Bus. Development Officer"}}],"security":"Ordinary Shares","published_at":"2026-09-11T20:30:14.000Z","date":"2026-09-09","kind":"sale","planned":false,"acquired":false,"shares":107978,"price":0.74,"value":79903.72,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares (\"ADS\"). Each 10 ADSs represent 23 Ordinary Shares of the Issuer."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The Reporting Person sold 46,947 ADSs representing approximately 107,978 ordinary shares in connection with the partial vesting of a restricted stock unit award on September 3, 2026, solely to satisfy tax withholding obligations incurred in connection with the vesting."},{"field":"shares","element":"transactionShares","label":"F3","text":"Reported securities are represented by 46,947 ADSs."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Reported sales price represents the converted sales price of the ADSs of $1.6908."}],"balance_after":266467,"source":{"system":"sec-edgar","filing":"0002109966-26-000008","document":"form4-09112026_040901.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2109966/000210996626000008/form4-09112026_040901.xml","form_type":"4"}},{"id":3570572,"issuer":{"id":6324,"kind":"organization","name":"NovaBridge Biosciences","symbol":"NBP"},"owners":[{"id":35580,"kind":"person","name":"Cao Sean Wuxiong","position":1,"cik":"0002109966","reported_name":"Cao Sean Wuxiong","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Bus. Development Officer"}}],"security":"Restricted Share Units","published_at":"2026-09-08T21:51:01.000Z","date":"2026-09-03","kind":"exercise","planned":false,"acquired":false,"shares":45320,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ADS."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"On June 22, 2026, the Reporting Person was granted 181,280 RSUs.  The RSUs vested or shall vest over four years, with one-fourth vesting on September 3, 2026 and the balance vesting ratably over the subsequent 12 quarters on the third day of each third month."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"On June 22, 2026, the Reporting Person was granted 181,280 RSUs.  The RSUs vested or shall vest over four years, with one-fourth vesting on September 3, 2026 and the balance vesting ratably over the subsequent 12 quarters on the third day of each third month."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares (\"ADS\"). Each 10 ADSs represent 23 Ordinary Shares of the Issuer."}],"balance_after":135960,"derivative":{"underlying":"Ordinary Shares","underlying_shares":45320},"source":{"system":"sec-edgar","filing":"0002109966-26-000006","document":"form4-09082026_090957.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/2109966/000210996626000006/form4-09082026_090957.xml","form_type":"4"}},{"id":3570571,"issuer":{"id":6324,"kind":"organization","name":"NovaBridge Biosciences","symbol":"NBP"},"owners":[{"id":35580,"kind":"person","name":"Cao Sean Wuxiong","position":1,"cik":"0002109966","reported_name":"Cao Sean Wuxiong","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Bus. Development Officer"}}],"security":"Restricted Share Units","published_at":"2026-09-08T21:51:01.000Z","date":"2026-09-03","kind":"exercise","planned":false,"acquired":false,"shares":102233,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ADS."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"On September 3, 2025, the Reporting Person was granted 408,933 RSUs. The RSUs vested or shall vest over four years, with one-fourth vesting on the first anniversary of the grant date and the balance vesting ratably over the subsequent 12 quarters on the third day of each third month."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"On September 3, 2025, the Reporting Person was granted 408,933 RSUs. The RSUs vested or shall vest over four years, with one-fourth vesting on the first anniversary of the grant date and the balance vesting ratably over the subsequent 12 quarters on the third day of each third month."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares (\"ADS\"). Each 10 ADSs represent 23 Ordinary Shares of the Issuer."}],"balance_after":306700,"derivative":{"underlying":"Ordinary Shares","underlying_shares":102233},"source":{"system":"sec-edgar","filing":"0002109966-26-000006","document":"form4-09082026_090957.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2109966/000210996626000006/form4-09082026_090957.xml","form_type":"4"}},{"id":3570570,"issuer":{"id":6324,"kind":"organization","name":"NovaBridge Biosciences","symbol":"NBP"},"owners":[{"id":35580,"kind":"person","name":"Cao Sean Wuxiong","position":1,"cik":"0002109966","reported_name":"Cao Sean Wuxiong","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Bus. Development Officer"}}],"security":"Ordinary Shares","published_at":"2026-09-08T21:51:01.000Z","date":"2026-09-03","kind":"exercise","planned":false,"acquired":true,"shares":104236,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares (\"ADS\"). Each 10 ADSs represent 23 Ordinary Shares of the Issuer."},{"field":"shares","element":"transactionShares","label":"F4","text":"Reported securities are represented by 45,320 ADSs."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ADS."}],"balance_after":374445,"source":{"system":"sec-edgar","filing":"0002109966-26-000006","document":"form4-09082026_090957.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2109966/000210996626000006/form4-09082026_090957.xml","form_type":"4"}},{"id":3570569,"issuer":{"id":6324,"kind":"organization","name":"NovaBridge Biosciences","symbol":"NBP"},"owners":[{"id":35580,"kind":"person","name":"Cao Sean Wuxiong","position":1,"cik":"0002109966","reported_name":"Cao Sean Wuxiong","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Bus. Development Officer"}}],"security":"Ordinary Shares","published_at":"2026-09-08T21:51:01.000Z","date":"2026-09-03","kind":"exercise","planned":false,"acquired":true,"shares":235136,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares (\"ADS\"). Each 10 ADSs represent 23 Ordinary Shares of the Issuer."},{"field":"shares","element":"transactionShares","label":"F2","text":"Reported securities are represented by 102,233 ADSs"},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ADS."}],"balance_after":270209,"source":{"system":"sec-edgar","filing":"0002109966-26-000006","document":"form4-09082026_090957.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2109966/000210996626000006/form4-09082026_090957.xml","form_type":"4"}},{"id":670798,"issuer":{"id":6324,"kind":"organization","name":"NovaBridge Biosciences","symbol":"NBP"},"owners":[{"id":17828,"kind":"person","name":"Xu Cong Claire","position":1,"cik":"0002114309","reported_name":"Xu Cong Claire","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Clinical Development"}}],"security":"Restricted Share Units","published_at":"2026-09-01T22:00:08.000Z","date":"2026-08-30","kind":"exercise","planned":false,"acquired":false,"shares":4079,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ADS."},{"field":"shares","element":"transactionShares","label":"F8","text":"Reported securities represent ADSs."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"On May 30, 2024, the Reporting Person was granted 65,270 RSUs. The RSUs vested or shall vest over four years, with one-fourth vesting on the first anniversary of the grant date and the balance vesting ratably over the subsequent 12 quarters on the 30th day of each third month."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F9","text":"On May 30, 2024, the Reporting Person was granted 65,270 RSUs. The RSUs vested or shall vest over four years, with one-fourth vesting on the first anniversary of the grant date and the balance vesting ratably over the subsequent 12 quarters on the 30th day of each third month."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares (\"ADS\"). Each 10 ADSs represent 23 Ordinary Shares of the Issuer."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F8","text":"Reported securities represent ADSs."}],"balance_after":28558,"derivative":{"underlying":"Ordinary Shares","underlying_shares":4079},"source":{"system":"sec-edgar","filing":"0002114309-26-000007","document":"form4-09012026_060901.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1778016/000211430926000007/form4-09012026_060901.xml","form_type":"4"}},{"id":670797,"issuer":{"id":6324,"kind":"organization","name":"NovaBridge Biosciences","symbol":"NBP"},"owners":[{"id":17828,"kind":"person","name":"Xu Cong Claire","position":1,"cik":"0002114309","reported_name":"Xu Cong Claire","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Clinical Development"}}],"security":"Ordinary Shares","published_at":"2026-09-01T22:00:08.000Z","date":"2026-08-31","kind":"sale","planned":false,"acquired":false,"shares":3282,"price":0.79,"value":2592.78,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares (\"ADS\"). Each 10 ADSs represent 23 Ordinary Shares of the Issuer."},{"field":"shares","element":"transactionShares","label":"F5","text":"Reported securities are represented by 1,427 ADSs."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Reported sales price represents the converted sales price of the ADSs of $1.8186."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F7","text":"Reported securities are represented by 132,261 ADSs."}],"balance_after":304201,"source":{"system":"sec-edgar","filing":"0002114309-26-000007","document":"form4-09012026_060901.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1778016/000211430926000007/form4-09012026_060901.xml","form_type":"4"}},{"id":670796,"issuer":{"id":6324,"kind":"organization","name":"NovaBridge Biosciences","symbol":"NBP"},"owners":[{"id":17828,"kind":"person","name":"Xu Cong Claire","position":1,"cik":"0002114309","reported_name":"Xu Cong Claire","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Clinical Development"}}],"security":"Ordinary Shares","published_at":"2026-09-01T22:00:08.000Z","date":"2026-08-30","kind":"exercise","planned":false,"acquired":true,"shares":9382,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares (\"ADS\"). Each 10 ADSs represent 23 Ordinary Shares of the Issuer."},{"field":"shares","element":"transactionShares","label":"F2","text":"Reported securities are represented by 4,079 ADSs."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ADS."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Reported securities are represented by 133,688 ADSs."}],"balance_after":307483,"source":{"system":"sec-edgar","filing":"0002114309-26-000007","document":"form4-09012026_060901.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1778016/000211430926000007/form4-09012026_060901.xml","form_type":"4"}},{"id":676280,"issuer":{"id":6324,"kind":"organization","name":"NovaBridge Biosciences","symbol":"NBP"},"owners":[{"id":19968,"kind":"person","name":"Lenz Robert A.","position":1,"cik":"0001992908","reported_name":"Lenz Robert A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2026-08-25T20:15:13.000Z","date":"2026-08-22","kind":"exercise","planned":false,"acquired":false,"shares":7486,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ADS."},{"field":"shares","element":"transactionShares","label":"F4","text":"Reported securities represent ADSs."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"On August 22, 2025, the Reporting Person was granted 22,460 restricted share units (\"RSUs\"). The RSUs vested or shall vest over three years in three equal annual installments on August 22, 2026, 2027 and 2028."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"On August 22, 2025, the Reporting Person was granted 22,460 restricted share units (\"RSUs\"). The RSUs vested or shall vest over three years in three equal annual installments on August 22, 2026, 2027 and 2028."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Reported securities represent ADSs."}],"balance_after":14974,"derivative":{"underlying":"Ordinary Shares","underlying_shares":7486},"source":{"system":"sec-edgar","filing":"0001992908-26-000013","document":"form4-08252026_040807.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1992908/000199290826000013/form4-08252026_040807.xml","form_type":"4"}},{"id":676279,"issuer":{"id":6324,"kind":"organization","name":"NovaBridge Biosciences","symbol":"NBP"},"owners":[{"id":19968,"kind":"person","name":"Lenz Robert A.","position":1,"cik":"0001992908","reported_name":"Lenz Robert A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-08-25T20:15:13.000Z","date":"2026-08-22","kind":"exercise","planned":false,"acquired":true,"shares":17218,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares (\"ADS\"). Each 10 ADSs represent 23 Ordinary Shares of the Issuer."},{"field":"shares","element":"transactionShares","label":"F2","text":"Reported securities are represented by 7,486 ADSs."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ADS."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Reported securities are represented by 7,486 ADSs."}],"balance_after":17218,"source":{"system":"sec-edgar","filing":"0001992908-26-000013","document":"form4-08252026_040807.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1992908/000199290826000013/form4-08252026_040807.xml","form_type":"4"}},{"id":710994,"issuer":{"id":6324,"kind":"organization","name":"NovaBridge Biosciences","symbol":"NBP"},"owners":[{"id":30930,"kind":"person","name":"Hagler Mark Arnold","position":1,"cik":"0002126029","reported_name":"Hagler Mark Arnold","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"2025 Employee Share Option (right to buy)","published_at":"2026-07-10T21:00:15.000Z","date":"2026-07-08","kind":"grant","planned":false,"acquired":true,"shares":949050,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Number of underlying securities and exercise price expressed in terms of American Depositary Shares (\"ADS\")."},{"field":"shares","element":"transactionShares","label":"F1","text":"Number of underlying securities and exercise price expressed in terms of American Depositary Shares (\"ADS\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests and becomes exercisable in four equal annual installments beginning on the first anniversary of April 17, 2026."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F3","text":"The Ordinary Shares may be represented by ADSs. Each 10 ADSs represent 23 Ordinary Shares of the Issuer."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"Number of underlying securities and exercise price expressed in terms of American Depositary Shares (\"ADS\")."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Number of underlying securities and exercise price expressed in terms of American Depositary Shares (\"ADS\")."}],"balance_after":949050,"derivative":{"exercise_price":1.93,"expiration_date":"2036-07-08","underlying":"Ordinary Shares","underlying_shares":949050},"source":{"system":"sec-edgar","filing":"0002126029-26-000003","document":"form4-07102026_050705.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1778016/000212602926000003/form4-07102026_050705.xml","form_type":"4"}},{"id":710993,"issuer":{"id":6324,"kind":"organization","name":"NovaBridge Biosciences","symbol":"NBP"},"owners":[{"id":30929,"kind":"person","name":"Lin Liwei Lorraine","position":1,"cik":"0002114156","reported_name":"Lin Liwei Lorraine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"2025 Employee Share Option (right to buy)","published_at":"2026-07-10T21:00:11.000Z","date":"2026-07-08","kind":"grant","planned":false,"acquired":true,"shares":254780,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Number of underlying securities and exercise price expressed in terms of American Depositary Shares (\"ADS\")."},{"field":"shares","element":"transactionShares","label":"F1","text":"Number of underlying securities and exercise price expressed in terms of American Depositary Shares (\"ADS\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests and becomes exercisable over five years, with 40% vesting on the second anniversary of February 1, 2026 and the balance vesting in three equal annual installments thereafter."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F3","text":"The Ordinary Shares may be represented by ADSs. Each 10 ADSs represent 23 Ordinary Shares of the Issuer."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"Number of underlying securities and exercise price expressed in terms of American Depositary Shares (\"ADS\")."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Number of underlying securities and exercise price expressed in terms of American Depositary Shares (\"ADS\")."}],"balance_after":254780,"derivative":{"exercise_price":1.93,"expiration_date":"2036-07-08","underlying":"Ordinary Shares","underlying_shares":254780},"source":{"system":"sec-edgar","filing":"0002114156-26-000003","document":"form4-07102026_050707.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1778016/000211415626000003/form4-07102026_050707.xml","form_type":"4"}},{"id":712887,"issuer":{"id":6324,"kind":"organization","name":"NovaBridge Biosciences","symbol":"NBP"},"owners":[{"id":31463,"kind":"person","name":"Gupta Srishti","position":1,"cik":"0002024011","reported_name":"Gupta Srishti","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"2025 Employee Share Option (right to buy)","published_at":"2026-07-08T20:26:25.000Z","date":"2026-07-06","kind":"grant","planned":false,"acquired":true,"shares":3000000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Number of underlying securities and exercise price expressed in terms of American Depositary Shares (\"ADS\")."},{"field":"shares","element":"transactionShares","label":"F1","text":"Number of underlying securities and exercise price expressed in terms of American Depositary Shares (\"ADS\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests and becomes exercisable in four equal annual installments beginning on the first anniversary of July 1, 2026."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F3","text":"The Ordinary Shares may be represented by ADSs. Each 10 ADSs represent 23 Ordinary Shares of the Issuer."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"Number of underlying securities and exercise price expressed in terms of American Depositary Shares (\"ADS\")."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Number of underlying securities and exercise price expressed in terms of American Depositary Shares (\"ADS\")."}],"balance_after":3000000,"derivative":{"exercise_price":2.01,"expiration_date":"2036-07-06","underlying":"Ordinary Shares","underlying_shares":3000000},"source":{"system":"sec-edgar","filing":"0002024011-26-000006","document":"form4-07082026_080720.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2024011/000202401126000006/form4-07082026_080720.xml","form_type":"4"}},{"id":713337,"issuer":{"id":6324,"kind":"organization","name":"NovaBridge Biosciences","symbol":"NBP"},"owners":[{"id":17828,"kind":"person","name":"Xu Cong Claire","position":1,"cik":"0002114309","reported_name":"Xu Cong Claire","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Clinical Development"}}],"security":"Restricted Share Units","published_at":"2026-07-07T23:50:18.000Z","date":"2026-07-04","kind":"exercise","planned":false,"acquired":false,"shares":5405,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ADS."},{"field":"shares","element":"transactionShares","label":"F8","text":"Reported securities represent ADSs."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"Fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F9","text":"Fully vested."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares (\"ADS\"). Each 10 ADSs represent 23 Ordinary Shares of the Issuer."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F8","text":"Reported securities represent ADSs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F8","text":"Reported securities represent ADSs."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":5405},"source":{"system":"sec-edgar","filing":"0002114309-26-000005","document":"form4-07072026_110715.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1778016/000211430926000005/form4-07072026_110715.xml","form_type":"4"}},{"id":713336,"issuer":{"id":6324,"kind":"organization","name":"NovaBridge Biosciences","symbol":"NBP"},"owners":[{"id":17828,"kind":"person","name":"Xu Cong Claire","position":1,"cik":"0002114309","reported_name":"Xu Cong Claire","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Clinical Development"}}],"security":"Ordinary Shares","published_at":"2026-07-07T23:50:18.000Z","date":"2026-07-06","kind":"sale","planned":false,"acquired":false,"shares":4485,"price":0.89,"value":3991.65,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares (\"ADS\"). Each 10 ADSs represent 23 Ordinary Shares of the Issuer."},{"field":"shares","element":"transactionShares","label":"F5","text":"Reported securities are represented by 1,950 ADSs."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Reported sales price represents the converted sales price of the ADSs of $2.04."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F7","text":"Reported securities are represented by 129,609 ADSs."}],"balance_after":298101,"source":{"system":"sec-edgar","filing":"0002114309-26-000005","document":"form4-07072026_110715.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1778016/000211430926000005/form4-07072026_110715.xml","form_type":"4"}},{"id":713335,"issuer":{"id":6324,"kind":"organization","name":"NovaBridge Biosciences","symbol":"NBP"},"owners":[{"id":17828,"kind":"person","name":"Xu Cong Claire","position":1,"cik":"0002114309","reported_name":"Xu Cong Claire","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Clinical Development"}}],"security":"Ordinary Shares","published_at":"2026-07-07T23:50:18.000Z","date":"2026-07-04","kind":"exercise","planned":false,"acquired":true,"shares":12432,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares (\"ADS\"). Each 10 ADSs represent 23 Ordinary Shares of the Issuer."},{"field":"shares","element":"transactionShares","label":"F2","text":"Reported securities are represented by 5,405 ADSs."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ADS."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Reported securities are represented by 131,559 ADSs."}],"balance_after":302586,"source":{"system":"sec-edgar","filing":"0002114309-26-000005","document":"form4-07072026_110715.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1778016/000211430926000005/form4-07072026_110715.xml","form_type":"4"}},{"id":722535,"issuer":{"id":6324,"kind":"organization","name":"NovaBridge Biosciences","symbol":"NBP"},"owners":[{"id":34397,"kind":"person","name":"Fu Wei","position":1,"cik":"0001885756","reported_name":"Fu Wei","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2026-06-30T20:15:24.000Z","date":"2026-06-29","kind":"grant","planned":false,"acquired":true,"shares":1010100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ADS."},{"field":"shares","element":"transactionShares","label":"F1","text":"Number of underlying securities and exercise price expressed in terms of American Depositary Shares (\"ADS\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The RSUs vest over two years in equal annual installments on June 29, 2027 and June 29, 2028."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"The RSUs vest over two years in equal annual installments on June 29, 2027 and June 29, 2028."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F3","text":"The Ordinary Shares may be represented by ADSs. Each 10 ADSs represent 23 Ordinary Shares of the Issuer."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"Number of underlying securities and exercise price expressed in terms of American Depositary Shares (\"ADS\")."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Number of underlying securities and exercise price expressed in terms of American Depositary Shares (\"ADS\")."}],"balance_after":1010100,"derivative":{"underlying":"Ordinary Shares","underlying_shares":1010100},"source":{"system":"sec-edgar","filing":"0001885756-26-000005","document":"form4-06302026_040618.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1778016/000188575626000005/form4-06302026_040618.xml","form_type":"4"}},{"id":722534,"issuer":{"id":6324,"kind":"organization","name":"NovaBridge Biosciences","symbol":"NBP"},"owners":[{"id":34397,"kind":"person","name":"Fu Wei","position":1,"cik":"0001885756","reported_name":"Fu Wei","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"2025 Employee Share Option (right to buy)","published_at":"2026-06-30T20:15:24.000Z","date":"2026-06-29","kind":"grant","planned":false,"acquired":true,"shares":1087720,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Number of underlying securities and exercise price expressed in terms of American Depositary Shares (\"ADS\")."},{"field":"shares","element":"transactionShares","label":"F1","text":"Number of underlying securities and exercise price expressed in terms of American Depositary Shares (\"ADS\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option vests, if at all, in eight equal quarterly installments following the date on which the 30-trading-day weighted average price of the Issuer's ADS (based on trading days only) is at or above US$16.00."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F3","text":"The Ordinary Shares may be represented by ADSs. Each 10 ADSs represent 23 Ordinary Shares of the Issuer."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"Number of underlying securities and exercise price expressed in terms of American Depositary Shares (\"ADS\")."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Number of underlying securities and exercise price expressed in terms of American Depositary Shares (\"ADS\")."}],"balance_after":1087720,"derivative":{"exercise_price":2.45,"expiration_date":"2036-06-29","underlying":"Ordinary Shares","underlying_shares":1087720},"source":{"system":"sec-edgar","filing":"0001885756-26-000005","document":"form4-06302026_040618.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1778016/000188575626000005/form4-06302026_040618.xml","form_type":"4"}},{"id":722533,"issuer":{"id":6324,"kind":"organization","name":"NovaBridge Biosciences","symbol":"NBP"},"owners":[{"id":34397,"kind":"person","name":"Fu Wei","position":1,"cik":"0001885756","reported_name":"Fu Wei","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"2025 Employee Share Option (right to buy)","published_at":"2026-06-30T20:15:24.000Z","date":"2026-06-29","kind":"grant","planned":false,"acquired":true,"shares":1087720,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Number of underlying securities and exercise price expressed in terms of American Depositary Shares (\"ADS\")."},{"field":"shares","element":"transactionShares","label":"F1","text":"Number of underlying securities and exercise price expressed in terms of American Depositary Shares (\"ADS\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option vests, if at all, in eight equal quarterly installments following the date on which the 30-trading-day weighted average price of the Issuer's ADS (based on trading days only) is at or above US$12.00."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F3","text":"The Ordinary Shares may be represented by ADSs. Each 10 ADSs represent 23 Ordinary Shares of the Issuer."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"Number of underlying securities and exercise price expressed in terms of American Depositary Shares (\"ADS\")."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Number of underlying securities and exercise price expressed in terms of American Depositary Shares (\"ADS\")."}],"balance_after":1087720,"derivative":{"exercise_price":2.45,"expiration_date":"2036-06-29","underlying":"Ordinary Shares","underlying_shares":1087720},"source":{"system":"sec-edgar","filing":"0001885756-26-000005","document":"form4-06302026_040618.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1778016/000188575626000005/form4-06302026_040618.xml","form_type":"4"}},{"id":722532,"issuer":{"id":6324,"kind":"organization","name":"NovaBridge Biosciences","symbol":"NBP"},"owners":[{"id":34397,"kind":"person","name":"Fu Wei","position":1,"cik":"0001885756","reported_name":"Fu Wei","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"2025 Employee Share Option (right to buy)","published_at":"2026-06-30T20:15:24.000Z","date":"2026-06-29","kind":"grant","planned":false,"acquired":true,"shares":725140,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Number of underlying securities and exercise price expressed in terms of American Depositary Shares (\"ADS\")."},{"field":"shares","element":"transactionShares","label":"F1","text":"Number of underlying securities and exercise price expressed in terms of American Depositary Shares (\"ADS\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests, if at all, in eight equal quarterly installments following the date on which the 30-trading-day weighted average price of the Issuer's ADS (based on trading days only) is at or above US$8.00."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F3","text":"The Ordinary Shares may be represented by ADSs. Each 10 ADSs represent 23 Ordinary Shares of the Issuer."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"Number of underlying securities and exercise price expressed in terms of American Depositary Shares (\"ADS\")."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Number of underlying securities and exercise price expressed in terms of American Depositary Shares (\"ADS\")."}],"balance_after":725140,"derivative":{"exercise_price":2.45,"expiration_date":"2036-06-29","underlying":"Ordinary Shares","underlying_shares":725140},"source":{"system":"sec-edgar","filing":"0001885756-26-000005","document":"form4-06302026_040618.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1778016/000188575626000005/form4-06302026_040618.xml","form_type":"4"}},{"id":727250,"issuer":{"id":6324,"kind":"organization","name":"NovaBridge Biosciences","symbol":"NBP"},"owners":[{"id":35580,"kind":"person","name":"Cao Sean Wuxiong","position":1,"cik":"0002109966","reported_name":"Cao Sean Wuxiong","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Bus. Development Officer"}}],"security":"2025 Employee Share Option (right to buy)","published_at":"2026-06-24T23:22:27.000Z","date":"2026-06-22","kind":"grant","planned":false,"acquired":true,"shares":181290,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Number of underlying securities and exercise price expressed in terms of ADSs."},{"field":"shares","element":"transactionShares","label":"F2","text":"Number of underlying securities and exercise price expressed in terms of ADSs."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option vests, if at all, in eight equal quarterly installments following the date on which the 30-trading-day weighted average price of the Issuer's ADS (based on trading days only) is at or above US$8.00."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F4","text":"The Ordinary Shares may be represented by ADSs. Each 10 ADSs represent 23 Ordinary Shares of the Issuer."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"Number of underlying securities and exercise price expressed in terms of ADSs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Number of underlying securities and exercise price expressed in terms of ADSs."}],"balance_after":181290,"derivative":{"exercise_price":1.53,"expiration_date":"2036-06-22","underlying":"Ordinary Shares","underlying_shares":181290},"source":{"system":"sec-edgar","filing":"0002109966-26-000004","document":"form4-06242026_110623.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1778016/000210996626000004/form4-06242026_110623.xml","form_type":"4"}},{"id":727249,"issuer":{"id":6324,"kind":"organization","name":"NovaBridge Biosciences","symbol":"NBP"},"owners":[{"id":35580,"kind":"person","name":"Cao Sean Wuxiong","position":1,"cik":"0002109966","reported_name":"Cao Sean Wuxiong","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Bus. Development Officer"}}],"security":"Restricted Share Units","published_at":"2026-06-24T23:22:27.000Z","date":"2026-06-22","kind":"grant","planned":false,"acquired":true,"shares":181280,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one American Depositary Shares (\"ADS\")."},{"field":"shares","element":"transactionShares","label":"F2","text":"Number of underlying securities and exercise price expressed in terms of ADSs."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs shall vest over four years, with one-fourth vesting on September 3, 2026 and the balance vesting ratably over the subsequent 12 quarters on the third day of each third month."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs shall vest over four years, with one-fourth vesting on September 3, 2026 and the balance vesting ratably over the subsequent 12 quarters on the third day of each third month."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F4","text":"The Ordinary Shares may be represented by ADSs. Each 10 ADSs represent 23 Ordinary Shares of the Issuer."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"Number of underlying securities and exercise price expressed in terms of ADSs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Number of underlying securities and exercise price expressed in terms of ADSs."}],"balance_after":181280,"derivative":{"underlying":"Ordinary Shares","underlying_shares":181280},"source":{"system":"sec-edgar","filing":"0002109966-26-000004","document":"form4-06242026_110623.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1778016/000210996626000004/form4-06242026_110623.xml","form_type":"4"}},{"id":729980,"issuer":{"id":6324,"kind":"organization","name":"NovaBridge Biosciences","symbol":"NBP"},"owners":[{"id":36207,"kind":"person","name":"Dennis Phillip Andrew","position":1,"cik":"0002089237","reported_name":"Dennis Phillip Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Share Units","published_at":"2026-06-22T21:23:50.000Z","date":"2026-06-17","kind":"exercise","planned":false,"acquired":false,"shares":10302,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ADS."},{"field":"shares","element":"transactionShares","label":"F8","text":"Reported securities represent ADSs."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"On June 17, 2024, the Reporting Person was granted 164,840 RSUs. The RSUs vested or shall vest over four years, with one-fourth vesting on the first anniversary of the grant date and the balance vesting ratably over the subsequent 12 quarters on the 17th day of each third month."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F9","text":"On June 17, 2024, the Reporting Person was granted 164,840 RSUs. The RSUs vested or shall vest over four years, with one-fourth vesting on the first anniversary of the grant date and the balance vesting ratably over the subsequent 12 quarters on the 17th day of each third month."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares (\"ADS\"). Each 10 ADSs represent 23 Ordinary Shares of the Issuer."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F8","text":"Reported securities represent ADSs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F8","text":"Reported securities represent ADSs."}],"balance_after":82422,"derivative":{"underlying":"Ordinary Shares","underlying_shares":10302},"source":{"system":"sec-edgar","filing":"0002089237-26-000006","document":"form4-06222026_090646.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1778016/000208923726000006/form4-06222026_090646.xml","form_type":"4"}},{"id":729979,"issuer":{"id":6324,"kind":"organization","name":"NovaBridge Biosciences","symbol":"NBP"},"owners":[{"id":36207,"kind":"person","name":"Dennis Phillip Andrew","position":1,"cik":"0002089237","reported_name":"Dennis Phillip Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2026-06-22T21:23:50.000Z","date":"2026-06-18","kind":"sale","planned":false,"acquired":false,"shares":8494,"price":0.66,"value":5606.04,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares (\"ADS\"). Each 10 ADSs represent 23 Ordinary Shares of the Issuer."},{"field":"shares","element":"transactionShares","label":"F5","text":"Reported securities are represented by 3,693 ADSs."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Reported sales price represents the converted sales price of the ADSs of $1.51."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F7","text":"Reported securities are represented by 68,670 ADSs."}],"balance_after":157941,"source":{"system":"sec-edgar","filing":"0002089237-26-000006","document":"form4-06222026_090646.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1778016/000208923726000006/form4-06222026_090646.xml","form_type":"4"}},{"id":729978,"issuer":{"id":6324,"kind":"organization","name":"NovaBridge Biosciences","symbol":"NBP"},"owners":[{"id":36207,"kind":"person","name":"Dennis Phillip Andrew","position":1,"cik":"0002089237","reported_name":"Dennis Phillip Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2026-06-22T21:23:50.000Z","date":"2026-06-17","kind":"exercise","planned":false,"acquired":true,"shares":23695,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares (\"ADS\"). Each 10 ADSs represent 23 Ordinary Shares of the Issuer."},{"field":"shares","element":"transactionShares","label":"F2","text":"Reported securities are represented by 10,302 ADSs."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ADS."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Reported securities are represented by 72,363 ADSs."}],"balance_after":166435,"source":{"system":"sec-edgar","filing":"0002089237-26-000006","document":"form4-06222026_090646.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1778016/000208923726000006/form4-06222026_090646.xml","form_type":"4"}},{"id":753951,"issuer":{"id":6324,"kind":"organization","name":"NovaBridge Biosciences","symbol":"NBP"},"owners":[{"id":17828,"kind":"person","name":"Xu Cong Claire","position":1,"cik":"0002114309","reported_name":"Xu Cong Claire","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Clinical Development"}}],"security":"Restricted Share Units","published_at":"2026-06-02T22:46:59.000Z","date":"2026-05-30","kind":"exercise","planned":false,"acquired":false,"shares":4079,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ADS."},{"field":"shares","element":"transactionShares","label":"F8","text":"Reported securities represent ADSs."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"On May 30, 2024, the Reporting Person was granted 65,270 RSUs. The RSUs vested or shall vest over four years, with one-fourth vesting on the first anniversary of the grant date and the balance vesting ratably over the subsequent 12 quarters on the 30th day of each third month."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F9","text":"On May 30, 2024, the Reporting Person was granted 65,270 RSUs. The RSUs vested or shall vest over four years, with one-fourth vesting on the first anniversary of the grant date and the balance vesting ratably over the subsequent 12 quarters on the 30th day of each third month."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares (\"ADS\"). Each 10 ADSs represent 23 Ordinary Shares of the Issuer."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F8","text":"Reported securities represent ADSs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F8","text":"Reported securities represent ADSs."}],"balance_after":32637,"derivative":{"underlying":"Ordinary Shares","underlying_shares":4079},"source":{"system":"sec-edgar","filing":"0002114309-26-000003","document":"form4-06022026_100655.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1778016/000211430926000003/form4-06022026_100655.xml","form_type":"4"}},{"id":753950,"issuer":{"id":6324,"kind":"organization","name":"NovaBridge Biosciences","symbol":"NBP"},"owners":[{"id":17828,"kind":"person","name":"Xu Cong Claire","position":1,"cik":"0002114309","reported_name":"Xu Cong Claire","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Clinical Development"}}],"security":"Ordinary Shares","published_at":"2026-06-02T22:46:59.000Z","date":"2026-06-01","kind":"sale","planned":false,"acquired":false,"shares":3494,"price":3.94,"value":13766.36,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares (\"ADS\"). Each 10 ADSs represent 23 Ordinary Shares of the Issuer."},{"field":"shares","element":"transactionShares","label":"F5","text":"Reported securities are represented by 1,519 ADSs."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Reported sales price represents the converted sales price of the ADSs of $1.71."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F7","text":"Reported securities are represented by 126,154 ADSs."}],"balance_after":290154,"source":{"system":"sec-edgar","filing":"0002114309-26-000003","document":"form4-06022026_100655.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1778016/000211430926000003/form4-06022026_100655.xml","form_type":"4"}},{"id":753949,"issuer":{"id":6324,"kind":"organization","name":"NovaBridge Biosciences","symbol":"NBP"},"owners":[{"id":17828,"kind":"person","name":"Xu Cong Claire","position":1,"cik":"0002114309","reported_name":"Xu Cong Claire","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Clinical Development"}}],"security":"Ordinary Shares","published_at":"2026-06-02T22:46:59.000Z","date":"2026-05-30","kind":"exercise","planned":false,"acquired":true,"shares":9382,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares (\"ADS\"). Each 10 ADSs represent 23 Ordinary Shares of the Issuer."},{"field":"shares","element":"transactionShares","label":"F2","text":"Reported securities are represented by 4,079 ADSs."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ADS."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Reported securities are represented by 127,673 ADSs."}],"balance_after":293648,"source":{"system":"sec-edgar","filing":"0002114309-26-000003","document":"form4-06022026_100655.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1778016/000211430926000003/form4-06022026_100655.xml","form_type":"4"}},{"id":774269,"issuer":{"id":6324,"kind":"organization","name":"NovaBridge Biosciences","symbol":"NBP"},"owners":[{"id":35580,"kind":"person","name":"Cao Sean Wuxiong","position":1,"cik":"0002109966","reported_name":"Cao Sean Wuxiong","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Ordinary Shares","published_at":"2026-05-18T20:05:10.000Z","date":"2026-05-14","kind":"sale","planned":false,"acquired":false,"shares":21399,"price":1.99,"value":42584.01,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares (\"ADS\"). Each 10 ADSs represent 23 Ordinary Shares of the Issuer."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The reporting person sold 9,304 ADSs representing approximately 21,399 ordinary shares in connection with the partial vesting of a restricted stock unit award on January 31, 2026, solely to satisfy tax withholding obligations incurred in connection with the vesting."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Price expressed in terms of ADSs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"The reported securities are represented by 15,249 ADSs."}],"balance_after":35073,"source":{"system":"sec-edgar","filing":"0001193125-26-228889","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1778016/000119312526228889/ownership.xml","form_type":"4"}},{"id":798570,"issuer":{"id":6324,"kind":"organization","name":"NovaBridge Biosciences","symbol":"NBP"},"owners":[{"id":30930,"kind":"person","name":"Hagler Mark Arnold","position":1,"cik":"0002126029","reported_name":"Hagler Mark Arnold","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Ordinary Shares","published_at":"2026-04-28T20:05:04.000Z","date":"2026-04-24","kind":"purchase","planned":false,"acquired":true,"shares":230000,"price":2.51,"value":577300.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares (\"ADS\"). Each 10 ADSs represent 23 Ordinary Shares of the Issuer."},{"field":"shares","element":"transactionShares","label":"F2","text":"The reported securities are represented by 100,000 ADSs."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These ADSs were purchased in multiple transactions at prices ranging from $2.44 to $2.54, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The reported securities are represented by 100,000 ADSs."}],"balance_after":230000,"source":{"system":"sec-edgar","filing":"0001193125-26-186924","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1778016/000119312526186924/ownership.xml","form_type":"4"}}]}